Intraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment study

Ophthalmology

Volumn 118, Issue 9, 2011, Pages 1766-1773

  Musch, David C ^a,b   Gillespie, Brenda W ^b   Niziol, Leslie M ^a   Lichter, Paul R ^a   Varma, Rohit ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TOPICAL TREATMENT; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; RISK FACTORS; TONOMETRY, OCULAR; TRABECULECTOMY; VISION DISORDERS; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 80051897270     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.01.047     Document Type: Article

References (34)

1. Eye Diseases Prevalence Research Group Prevalence of open-angle glaucoma among adults in the United States Arch Ophthalmol 122 2004 532 538
2. M.O. Gordon, J.A. Beiser, J.D. Brandt Ocular Hypertension Treatment Study Group The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma Arch Ophthalmol 120 2002 714 720 (Pubitemid 34620349)
3. A. Heijl, M.C. Leske, B. Bengtsson Early Manifest Glaucoma Trial Group Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 2002 1268 1279 (Pubitemid 36105431)
4. M.C. Leske, A. Heijl, M. Hussein Early Manifest Glaucoma Trial Group Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial Arch Ophthalmol 121 2003 48 56 (Pubitemid 36401765)
5. M.C. Leske, A. Heijl, L. Hyman EMGT Group Predictors of long-term progression in the Early Manifest Glaucoma Trial Ophthalmology 114 2007 1965 1972 (Pubitemid 350016362)
6. Collaborative Normal-Tension Glaucoma Study Group The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am J Ophthalmol 126 1998 498 505
7. AGIS Investigators The Advanced Glaucoma Intervention Study (AGIS): 7 The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 2000 429 440
8. D.C. Musch, P.R. Lichter, K.E. Guire CIGTS Study Group The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients Ophthalmology 106 1999 653 662 (Pubitemid 30194301)
9. B.W. Gillespie, D.C. Musch, K.E. Guire CIGTS Study Group The Collaborative Initial Glaucoma Treatment Study: baseline visual field and test-retest variability Invest Ophthalmol Vis Sci 44 2003 2613 2620 (Pubitemid 36618421)
10. D.C. Musch, B.W. Gillespie, L.M. Niziol Collaborative Initial Glaucoma Treatment Study Group Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study Ophthalmology 115 2008 927 933 (Pubitemid 351749685)
11. M.A. Kass Standardizing the measurement of intraocular pressure for clinical research: guidelines from the Eye Care Technology Forum Ophthalmology 103 1996 183 185 (Pubitemid 26046178)
12. N.M. Laird, and J.H. Ware Random-effects models for longitudinal data Biometrics 38 1982 963 974
13. K.Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrika 73 1986 13 22
14. D.C. Musch, B.W. Gillespie, P.R. Lichter CIGTS Study Investigators Visual field progression in the Collaborative Initial Glaucoma Treatment Study: the impact of treatment and other baseline factors Ophthalmology 116 2009 200 207
15. D.M. Eddy, and J. Billings The quality of medical evidence: implications for quality of care Health Aff (Millwood) 7 1988 19 32 (Pubitemid 18080570)
16. J. Caprioli Intraocular pressure fluctuation: an independent risk factor for glaucoma? Arch Ophthalmol 125 2007 1124 1125 (Pubitemid 47258048)
17. E.B. Werner, S.M. Drance, and M. Schulzer Trabeculectomy and the progression of glaucomatous visual field loss Arch Ophthalmol 95 1977 1374 1377 (Pubitemid 8142300)
18. C. O'Brien, B. Schwartz, T. Takamoto, and D.C. Wu Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma Am J Ophthalmol 111 1991 491 500
19. W.C. Stewart, R.P. Chorak, H.H. Hunt, and G. Sethuraman Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head Am J Ophthalmol 116 1993 176 181 (Pubitemid 23229078)
20. W.C. Stewart, A.E. Kolker, and E.D. Sharpe Factors associated with long-term progression or stability in primary open-angle glaucoma Am J Ophthalmol 130 2000 274 279
21. B. Bergea, L. Bodin, and B. Svedbergh Impact of intraocular pressure regulation on visual fields in open-angle glaucoma Ophthalmology 106 1999 997 1004
22. S. Hong, G.J. Seong, and Y.J. Hong Long-term intraocular pressure fluctuation and progressive visual field deterioration in patients with glaucoma and low intraocular pressures after a triple procedure Arch Ophthalmol 125 2007 1010 1013 (Pubitemid 47258028)
23. P.P. Lee, J.W. Walt, L.C. Rosenblatt Glaucoma Care Study Group Association between intraocular pressure variation and glaucoma progression: data from a United States chart review Am J Ophthalmol 144 2007 901 907
24. K. Nouri-Mahdavi, D. Hoffman, and A.L. Coleman Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study Ophthalmology 111 2004 1627 1635 (Pubitemid 39179673)
25. J. Caprioli, and A.L. Coleman Intraocular pressure fluctuation: a risk factor for visual field progression at low intraocular pressures in the Advanced Glaucoma Intervention Study Ophthalmology 115 2008 1123 1129
26. B. Bengtsson, M.C. Leske, L. Hyman Early Manifest Glaucoma Trial Group Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial Ophthalmology 114 2007 205 209 (Pubitemid 46161799)
27. R. Varma, L.J. Hwang, J.W. Grunden, and G.W. Bean Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials Am J Ophthalmol 145 2008 336 342
28. C.A. Johnson Standardizing the measurement of visual fields for clinical research: guidelines from the Eye Care Technology Forum Ophthalmology 103 1996 186 189 (Pubitemid 26046179)
29. J. Katz, H.A. Quigley, and A. Sommer Detection of incident field loss using the glaucoma hemifield test Ophthalmology 103 1996 657 663 (Pubitemid 26114238)
30. J.L. Keltner, C.A. Johnson, J.M. Quigg Ocular Hypertension Treatment Study Group Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study Arch Ophthalmol 118 2000 1187 1194
31. J. Concato, A.R. Feinstein, and T.R. Holford The risk of determining risk with multivariable models Ann Intern Med 118 1993 201 210 (Pubitemid 23034807)
32. A.G. Konstas, F. Topouzis, and O. Leliopoulou 24-hour intraocular pressure control with maximum medical therapy compared with surgery in patients with advanced open-angle glaucoma Ophthalmology 113 2006 761 765
33. R. Varma, L.J. Hwang, and J.W. Grunden Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range Am J Ophthalmol 148 2009 221 226
34. L.J. Katz, and J.S. Myers Smoothing the intraocular pressure roller coaster: a new goal? Am J Ophthalmol 148 2009 177 178